These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9314831)

  • 21. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
    Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
    J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis.
    Li YC; Luo Q; Ge LS; Chen YH; Zhou ND; Zhang T; Guan XQ; Lin JF
    Biochem Biophys Res Commun; 2013 Feb; 431(3):450-5. PubMed ID: 23333383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of inducible nitric oxide synthase in experimental viral myocarditis.
    Glück B; Merkle I; Dornberger G; Stelzner A
    Herz; 2000 May; 25(3):255-60. PubMed ID: 10904848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wnt11 gene therapy with adeno-associated virus 9 improves the survival of mice with myocarditis induced by coxsackievirus B3 through the suppression of the inflammatory reaction.
    Aoyama Y; Kobayashi K; Morishita Y; Maeda K; Murohara T
    J Mol Cell Cardiol; 2015 Jul; 84():45-51. PubMed ID: 25886696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. L-arginine ameliorates experimental autoimmune myocarditis by maintaining extracellular matrix and reducing cytotoxic activity of lymphocytes.
    Okabe TA; Hattori M; Yuan Z; Kishimoto C
    Int J Exp Pathol; 2008 Oct; 89(5):382-8. PubMed ID: 18808530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
    Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
    Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial weight and virus dose: two factors affecting the onset of acute coxsackievirus B3 myocarditis in C57BL/6 mouse--a histopathology-based study.
    Li M; Wang X; Xie Y; Xie Y; Zhang X; Zou Y; Ge J; Chen R
    Cardiovasc Pathol; 2013; 22(1):96-101. PubMed ID: 22784985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis.
    Corsten MF; Papageorgiou A; Verhesen W; Carai P; Lindow M; Obad S; Summer G; Coort SL; Hazebroek M; van Leeuwen R; Gijbels MJ; Wijnands E; Biessen EA; De Winther MP; Stassen FR; Carmeliet P; Kauppinen S; Schroen B; Heymans S
    Circ Res; 2012 Aug; 111(4):415-25. PubMed ID: 22715471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic blockade of nitric oxide synthesis reduces adiposity and improves insulin resistance in high fat-induced obese mice.
    Tsuchiya K; Sakai H; Suzuki N; Iwashima F; Yoshimoto T; Shichiri M; Hirata Y
    Endocrinology; 2007 Oct; 148(10):4548-56. PubMed ID: 17584959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of apoptosis-related proteins in experimental coxsackievirus myocarditis.
    Colston JT; Chandrasekar B; Freeman GL
    Cardiovasc Res; 1998 Apr; 38(1):158-68. PubMed ID: 9683918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics of coxsackievirus B3 cardiovirulence.
    Tracy S; Tu Z; Chapman N; Hufnagel G
    Eur Heart J; 1995 Dec; 16 Suppl O():15-7. PubMed ID: 8682085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Protective effect of hydrogen sulfide on mice with experimental viral myocarditis and its mechanism].
    Qian H; Liu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):708-12. PubMed ID: 25001934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Protective effect and mechanism of IL-17 monoclonal antibody on mice with viral myocarditis].
    Qian H; Liu L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):509-12. PubMed ID: 24796747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coxsackievirus B3 infection induced viral myocarditis by regulating the expression pattern of chemokines in cardiac myocytes.
    Shen Y; Kan QC; Xu W; Chu YW; Xiong SD
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):1-9. PubMed ID: 19279353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardioprotective effect of NO-metoprolol in murine coxsackievirus B3-induced myocarditis.
    Glück B; Dahlke K; Zell R; Krumbholz A; Decker M; Lehmann J; Wutzler P
    J Med Virol; 2010 Dec; 82(12):2043-52. PubMed ID: 20981792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis.
    Hiraoka Y; Kishimoto C; Kurokawa M; Ochiai H; Sasayama S
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1386-91. PubMed ID: 1372051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of levosimendan in experimental acute coxsackievirus myocarditis.
    Latva-Hirvelä J; Kytö V; Saraste A; Vuorinen T; Levijoki J; Saukko P
    Eur J Clin Invest; 2009 Oct; 39(10):876-82. PubMed ID: 19772522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.